www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/aktien/Sequenom-verfehlt-Analystenerwartungen-Aktie-deutlich-leichter-758006San Diego (aktiencheck.de AG) - Die <a href="/aktienkurse.asp">Aktie</a> des US-Gesundheitskonzern <a href="/aktien/Sequenom_1-Aktie">Sequenom</a> Inc. musste zu Handelsbeginn am Dienstag deutliche Kursabschl&auml;ge ausweisen. <!-- sh_cad_1 --> Am Vorabend ...http://www.finanzen.net/nachricht/aktien/Sequenom-verfehlt-Analystenerwartungen-Aktie-deutlich-leichter-758006http://www.finanzen.net/nachricht/aktien/Glancy-Binkow-Goldberg-LLP-Representing-Investors-Who-Purchased-Sequenom-Inc-Announces-Class-Action-Lawsuit-and-Seeks-to-Recover-Losses-479195 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwunderlinestyle {text-decoration: underline} --> </style> Notice is hereby given that Glancy Binkow Goldberg LLP has filed a class action lawsuit in the United ...http://www.finanzen.net/nachricht/aktien/Glancy-Binkow-Goldberg-LLP-Representing-Investors-Who-Purchased-Sequenom-Inc-Announces-Class-Action-Lawsuit-and-Seeks-to-Recover-Losses-479195http://www.finanzen.net/nachricht/aktien/Coughlin-Stoia-Geller-Rudman-Robbins-LLP-Files-Class-Action-Suit-against-Sequenom-Inc-478314 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Coughlin Stoia Geller Rudman Robbins LLP ("Coughlin Stoia”) (<a href="http://cts.businesswire.com/ct/CT?id=smartlinkurl=http%3A%2F%2Fwww.csgrr.com%2Fcas ...http://www.finanzen.net/nachricht/aktien/Coughlin-Stoia-Geller-Rudman-Robbins-LLP-Files-Class-Action-Suit-against-Sequenom-Inc-478314http://www.finanzen.net/nachricht/aktien/Johnson-Bottini-LLP-Files-Class-Action-on-Behalf-of-Purchasers-of-Sequenom-Inc-478176 Johnson Bottini, LLP today announced that it has filed a class action lawsuit in United States District Court for the Southern District of California on behalf of all persons who purchased or otherwise acquired securities ...http://www.finanzen.net/nachricht/aktien/Johnson-Bottini-LLP-Files-Class-Action-on-Behalf-of-Purchasers-of-Sequenom-Inc-478176http://www.finanzen.net/nachricht/aktien/Law-Offices-of-Howard-G-Smith-Announces-Investigation-On-Behalf-of-Investors-of-Sequenom-Inc-478130 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Law Offices of Howard G. Smith announces that it is investigating potential claims against Sequenom, Inc. ("Sequenom” or the "Company”) (Nasdaq:SQNM), ...http://www.finanzen.net/nachricht/aktien/Law-Offices-of-Howard-G-Smith-Announces-Investigation-On-Behalf-of-Investors-of-Sequenom-Inc-478130http://www.finanzen.net/nachricht/aktien/SEQUENOM-Reports-First-Quarter-2009-Financial-Results-477094 <style type="text/css"> <!-- .bwcellpaddingbottom1 {padding-bottom: 2.0px} .bwcellpaddingbottom3 {padding-bottom: 4.0px} .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingright0 {padding-right: 0.0px} .bwcellparagraphmargin {margin-bottom: 0px; ...http://www.finanzen.net/nachricht/aktien/SEQUENOM-Reports-First-Quarter-2009-Financial-Results-477094http://www.finanzen.net/nachricht/aktien/SEQUENOM-Announces-Delay-in-Launch-of-SEQureDx-Trisomy-21-Test-477090 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <b>SEQUENOM, Inc. (NASDAQ: SQNM)</b> announced today that the expected launch of its SEQureDx™ Down syndrome test is delayed, due to the discovery ...http://www.finanzen.net/nachricht/aktien/SEQUENOM-Announces-Delay-in-Launch-of-SEQureDx-Trisomy-21-Test-477090http://www.finanzen.net/nachricht/aktien/SEQUENOM-Announces-Cost-Cutting-Initiative-in-Genetic-Analysis-Business-473845 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <b>SEQUENOM, Inc. (NASDAQ: SQNM)</b> today announced that as a result of the continuing weak outlook in 2009 for capital equipment sales, particularly ...http://www.finanzen.net/nachricht/aktien/SEQUENOM-Announces-Cost-Cutting-Initiative-in-Genetic-Analysis-Business-473845http://www.finanzen.net/nachricht/aktien/Sequenom-to-Present-at-Two-Investment-Community-Conferences-in-March-452975 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> Sequenom, Inc. (NASDAQ:SQNM), a leading provider of genetic analysis solutions, today announced that ...http://www.finanzen.net/nachricht/aktien/Sequenom-to-Present-at-Two-Investment-Community-Conferences-in-March-452975http://www.finanzen.net/nachricht/aktien/Sequenom-to-Present-at-Two-Investment-Community-Conferences-in-March-452986 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> Sequenom, Inc. (NASDAQ:SQNM), a leading provider of genetic analysis solutions, today announced that ...http://www.finanzen.net/nachricht/aktien/Sequenom-to-Present-at-Two-Investment-Community-Conferences-in-March-452986